Technology
Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials
CRAYON summary
TechCrunch reports that Isomorphic Labs, an AI drug-discovery platform spun out of Google's DeepMind in 2021, has raised $5 billion in a Series C funding round. According to the headline, the company is looking to take drug candidates to clinical trials.
Based on TechCrunch's report - only one outlet has covered this so far. Read the original.▲ Sign in to vote stories up
Coverage 1 source · 1 report
Chronological.
-
Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 Billion in a Series C funding round.
Discussion 0 comments